World PulseNow
Financial MarketsThe Wall Street JournalTue, Jun 23, 2026, 9:08 PMNegative

Nike Names Pfizer’s Denton as Next CFO

Nike has appointed David Denton, previously of Pfizer, as its new Chief Financial Officer, effective August 17. This change comes amid significant challenges for the company, including declining sales in its key Chinese market and weaknesses in the Europe, Middle East, and Africa regions.

WPN Brief

  • What Happened

    Nike has appointed David Denton, previously of Pfizer, as its new Chief Financial Officer, effective August 17. This change comes amid significant challenges for the company, including declining sales in its key Chinese market and weaknesses in the Europe, Middle East, and Africa regions.

  • Why It Matters

    Denton's appointment is critical as Nike seeks to navigate a difficult financial landscape and execute a turnaround strategy. The company has faced unexpected sales drops, which could impact its overall market position and investor confidence.

  • The Bigger Picture

    The leadership change reflects ongoing struggles within Nike, particularly in addressing persistent weaknesses in the Chinese market, which have been highlighted by analysts. This situation underscores the broader challenges facing global brands in adapting to fluctuating market dynamics and consumer preferences.

Ask WPN AI